• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . Impact of Kidney Failure on the Severity of COVID-19

tetano

Editor, Senior Moderator
J Clin Med


. 2021 May 10;10(9):2042.
doi: 10.3390/jcm10092042.
Impact of Kidney Failure on the Severity of COVID-19


Dorota Zarębska-Michaluk[SUP] 1 [/SUP], Jerzy Jaroszewicz[SUP] 2 [/SUP], Magdalena Rogalska[SUP] 3 [/SUP], Beata Lorenc[SUP] 4 [/SUP], Marta Rorat[SUP] 5 6 [/SUP], Anna Szymanek-Pasternak[SUP] 5 [/SUP], Anna Piekarska[SUP] 7 [/SUP], Aleksandra Berkan-Kawińska[SUP] 7 [/SUP], Katarzyna Sikorska[SUP] 8 [/SUP], Magdalena Tudrujek-Zdunek[SUP] 9 [/SUP], Barbara Oczko-Grzesik[SUP] 2 [/SUP], Beata Bolewska[SUP] 10 [/SUP], Piotr Czupryna[SUP] 11 [/SUP], Dorota Kozielewicz[SUP] 12 [/SUP], Justyna Kowalska[SUP] 13 [/SUP], Regina Podlasin[SUP] 14 [/SUP], Krzysztof Kłos[SUP] 15 [/SUP], Włodzimierz Mazur[SUP] 16 [/SUP], Piotr Leszczyński[SUP] 17 18 [/SUP], Bartosz Szetela[SUP] 19 [/SUP], Katarzyna Reczko[SUP] 1 [/SUP], Robert Flisiak[SUP] 3 [/SUP]



Affiliations
Free article

Abstract

Background: Patients with kidney failure are at an increased risk of progression to a severe form of coronavirus disease 2019 (COVID-19) with high mortality. The current analysis was aimed to assess the impact of renal failure on the severity of COVID-19 and identify the risk factors of the fatal outcome in this population.
Methods: The analysis included patients from the SARSTer database, a national real-world study evaluating treatment for COVID-19 in 30 Polish centers. Data were completed retrospectively and submitted online.
Results: A total of 2322 patients were included in the analysis. Kidney failure was diagnosed in 455 individuals (19.65%), of whom 373 presented moderate stage and 82 patients, including 14 dialysis individuals, presented severe renal failure. Patients with kidney failure were significantly older and demonstrated a more severe course of COVID-19. The age, baseline SpO[SUB]2[/SUB], the ordinal scale of 4 and 5, neutrophil and platelet count, estimated glomerular filtration rate, and C-reactive protein concentration as well as malignancy and arterial hypertension were the independent predictors of 28-day mortality in logistic regression analysis.
Conclusions: Underlying kidney disease in patients with COVID-19 is among the leading factors associated with a higher risk of severe clinical presentation and increased mortality rate.

Keywords: COVID-19; SARS-CoV-2; kidney failure; mortality.
 
Back
Top Bottom